Hanseatic Management Services’s West Pharmaceutical WST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$605K Buy
+1,633
New +$576K 0.5% 63
2023
Q4
– Sell
-1,448
Closed -$543K – 145
2023
Q3
$543K Buy
1,448
+12
+0.8% +$4.64K 1.01% 38
2023
Q2
$549K Buy
+1,436
New +$513K 1.01% 34
2022
Q1
– Sell
-49
Closed -$23K – 188
2021
Q4
$23K Hold
49
– – 0.04% 92
2021
Q3
$21K Buy
+49
New +$20.7K 0.04% 100
2021
Q1
– Sell
-60
Closed -$17K – 182
2020
Q4
$17K Hold
60
– – 0.04% 107
2020
Q3
$16K Sell
60
-4,850
-99% -$1.28M 0.04% 138
2020
Q2
$1.12M Sell
4,910
-1,743
-26% -$342K 0.94% 33
2020
Q1
$1.01M Sell
6,653
-243
-4% -$37.4K 1.08% 19
2019
Q4
$1.04M Buy
+6,896
New +$1M 0.95% 25
2019
Q1
– Sell
-203
Closed -$20K – 317
2018
Q4
$20K Buy
+203
New +$22K 0.03% 158
2016
Q1
– Sell
-14
Closed -$1K – 330
2015
Q4
$1K Buy
+14
New +$842 ﹤0.01% 287

Other funds holding WST

Hanseatic Management Services's WST Position: Q3 2026 in Review

Hanseatic Management Services opened a new position in West Pharmaceutical (WST) in Q3 2026: 1,633 shares worth $605K. The stake represents 0.5% of the portfolio and ranks #63 among its holdings. This is a return to the name: Hanseatic Management Services previously reported a position in WST as recently as Q3 2023.

Hanseatic Management Services first reported a position in WST in Q4 2015 and has held it in 12 quarters since. The position peaked at $1.12M in Q2 2020. 254 funds tracked by Wall St. Rank hold WST as of Q3 2026.

  • Hanseatic Management Services held 1,633 shares of West Pharmaceutical worth $605K as of Q3 2026.
  • West Pharmaceutical was a new Hanseatic Management Services position in Q3 2026.
  • West Pharmaceutical made up 0.5% of Hanseatic Management Services's portfolio in Q3 2026, its #63 holding.
  • Hanseatic Management Services first reported a position in West Pharmaceutical in Q4 2015 and has held it in 12 quarters since.
  • Hanseatic Management Services's West Pharmaceutical position peaked at $1.12M in Q2 2020.
  • 254 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2026.

Based on Hanseatic Management Services's 13F filing for Q3 2026, filed 22 Oct 2026.